PLEXUS
LIVE

Serial Number

79171662

Owner

Vascutek Limited

Attorney

Megan E. Fink

Filing Date

Dec 22, 2014

Add to watchlist:

No watchlists yet
View on USPTO

PLEXUS Trademark

Serial Number: 79171662 • Registration: 5024473

PLEXUS is a trademark filed by Vascutek Limited on December 22, 2014. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Vascutek Limited

Newmains Avenue
Renfrewshire PA4 9RR , GB

Entity Type: 11

Trademark Details

Filing Date

December 22, 2014

Registration Date

August 23, 2016

Published for Opposition

June 7, 2016

Goods & Services

Surgical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease, namely, thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, namely, surgical mesh comprised primarily of prosthetic materials; medical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease; grafts, namely, prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; stents, patches, namely, patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; prostheses, namely, artificial surgical prostheses; surgical implants comprising artificial material; suture materials; patches for repair and reconstruction of internal tissue, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, synthetic heart valve conduits, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; artificial vascular grafts; artificial endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease medical devices for use in endovascular procedures for treating cardiovascular disease; stents; thoracic stents; artificial thoracic stent grafts; thoracic stent graft systems comprising synthetic stent grafts and stent delivery systems; delivery systems for stent graft systems comprising stent delivery systems; aneurysm repair systems comprised of catheter delivered artificial stent grafts and stent delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems comprised of artificial cardiac valves; artificial heart valves; heart valve conduits namely, catheters for implanting heart valves; cardiac patches and vascular patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2026 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 23, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Oct 24, 2024 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 11, 2022 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 11, 2022 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 6, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Dec 21, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 23, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 17, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 19, 2017 FICS
FINAL DISPOSITION PROCESSED
Jan 19, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 28, 2016 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 1, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 30, 2016 PREV
ASSIGNED TO LIE
Apr 29, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 28, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 28, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 28, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 28, 2016 CNEA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 29, 2016 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 29, 2016 TEME
ASSIGNED TO LIE
Mar 29, 2016 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2016 CRFA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2016 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2016 TROA
REFUSAL PROCESSED BY IB
Oct 2, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 15, 2015 RFCS
REFUSAL PROCESSED BY MPU
Sep 15, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2015 RFCR
NON-FINAL ACTION WRITTEN
Sep 11, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 8, 2015 MAFR
ASSIGNED TO EXAMINER
Sep 4, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2015 REPR